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Abstract
A brief, enantioselective synthesis of a hydroxymethyl-cis-1,3-cyclopentenediol building block is
presented. This scaffold allows access to the cis-1,3-cyclopentanediol fragments found in a variety
of biologically active natural and non-natural products. This rapid and efficient synthesis is
highlighted by the utilization of the palladium-catalyzed enantioselective allylic alkylation of
dioxanone substrates to prepare tertiary alcohols.
Functionalized cyclopentanol frameworks are an important structural motif in organic
chemistry. Scaffolds of this type are found in many biologically active natural products,1
pharmaceuticals,2 and nucleoside analogs.3 In particular, cis-1,3-cyclopentanediols (1) have
been extensively employed in the synthesis of medicinally relevant natural and non-natural
compounds.3,4 For example, the biologically active prostaglandin (e.g., 2 and
3)2,5furanocembranoid diterpene (e.g., 4 and 5), and norcembranoid diterpene families of
natural products (e.g., 6 and 7)1d,6 all contain the cis-1,3-cyclopentanediol motif (Figure 1).
Typically, enantioenriched carbocycles of this type have been accessed by kinetic
enzymatic7 or classical8 resolutions. The utility of cis-1,3-cyclopentanediols which contain a
tertiary alcohol is severely limited due to the challenges associated with the stereocontrolled
formation of such chiral centers. Literature examples of the asymmetric synthesis of this
moiety are limited to substrate-controlled diastereoselective alkylation4b or asymmetric
oxidation of prochiral substrates.9 To the best of our knowledge, the enantioselective
synthesis of the cis-1,3-cyclopentanediol scaffold has not been accomplished through
asymmetric alkylation. As such, in concert with our research program dedicated to the
development and application of the palladium-catalyzed asymmetric allylic alkylation,10 we
developed an efficient and general route for the enantioselective synthesis of cis-1,3-
cyclopentanediol building block 1.
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We envisioned that our asymmetric catalytic preparation of a cis-1,3-cyclopentanediol core
(1) with additional functional handles would serve as an enabling technology for various
total synthetic efforts. Specifically, we targeted diol 8, which can be synthesized from
cyclopentenone 9 following diastereoselective reduction and ketal cleavage (Scheme 1).
Intramolecular cyclization of dioxanone 10 would afford cyclopentenone 9. In turn, chiral
dioxanone 10 would be prepared by palladium-catalyzed asymmetric allylic alkylation of
silyl enol ether 11.
Our synthetic approach to cis-1,3-cyclopentenediol 8 was inspired by our previous report of
the synthesis of related enone 14 (Scheme 2a).10a–b,10e The palladium-catalyzed asymmetric
alkylation of enol ether 12 afforded allyl ketone 13 in 95% yield with 87% ee. Wacker
oxidation of the allyl fragment to the intermediate methyl ketone followed by intramolecular
aldol condensation generated cyclopentenone 14 in 73% yield over two steps from allylic
alkylation product 13.
Similarly, dimethyl ketal 15 was converted to chiral ketal 16 in 86% yield and 87% ee
through the enantioselective allylic alkylation procedure developed by our group (Scheme
2b).11 However, employment of the sequential Wacker oxidation–intramolecular aldol
cyclization conditions were found to be ineffective, in preparing cyclopentenone ketal 17.
Despite extensive exploration of alternative conditions for this transformation, formation of
enone 17 was never observed.12
Faced with this challenge, we envisioned preparation of cyclopentenone 17 by an
intramolecular Wittig cyclization (Scheme 3).13 The introduction of an oxidized allyl
fragment during the alkylation event to generate ketone 18 could facilitate the olefinic
oxidation. Subsequent nucleophilic substitution with a phosphine would generate Wittig
precursor 19. Exposure to basic conditions could generate the phosphonium ylide, thus
enabling an intramolecular Wittig cyclization to form cyclopentenone 17.
To explore this pathway, we began with chloroallylketone 20 which was prepared by
palladium-catalyzed asymmetric allylic alkylation in 59% yield and 92% ee by known
procedure (Scheme 4).14 Epoxidation of ketone 20 with m-CPBA generated intermediate
epoxide 21. Nucleophilic epoxide opening then formed the α-phosphinoketone in situ,
enabling the construction of enone 17 by intramolecular Wittig cyclization. Although the
yield for the two-step sequence was low and varied unpredictably, the desired
cyclopentenone 17 could be isolated in small quantities.
Having accomplished proof of principle, we turned our attention to optimization. Despite
screening a variety of epoxidation conditions,15 the synthesis of intermediate 21 proved
difficult and remained low yielding. The Wittig cyclization had similar constraints,
furnishing cyclopentenone 17 in variable, unsatisfactory yields.
In spite of this failed optimization, we remained inspired by the successful isolation of the
desired enone 17. As an alternative, we decided to explore the synthesis of other Wittig
cyclization precursors. One appealing option was to target intermediate α-bromoketone 22
(Scheme 5).13 Oxidative bromination of vinyl chloride 20 with NaOBr in AcOH resulted in
the formation of intermediate bromide 22. In situ displacement of the bromide by
triphenylphosphine and subsequent intramolecular Wittig cyclization furnished
cyclopentenone 17 with no erosion of enantiomeric excess, albeit in comparably
unpredictable yields.
Synthetic advancement of dioxanone 20 through α-bromoketone 22 was plagued by vast
inconsistencies and optimization proved difficult. The two-step sequence offered a range of
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yields from 0% to 82%. A variety of oxidative bromination conditions were attempted,15 yet
consistent yields could not be achieved. Importantly, when intermediate 22 was successfully
formed,16 conversion to cyclopentenone 17 could be reproducibly achieved with moderate
success, indicating that the oxidative bromination was the problematic step in the sequence.
Upon closer inspection of the oxidative α-bromination procedure, we identified two possible
sources of inconsistency. Firstly, we suspected that exposure of substrate 20 and
intermediate 22 to acetic acid was causing the ketal cleavage of both compounds throughout
the reaction, resulting in decomposition. Direct observation of this hypothesis was
challenging, as the cleavage of the dimethyl ketal simply generated additional quantities of
the reaction solvent, acetone. An additional source of variability arose as the scale of the
reaction was increased. Over the lengthy time course of addition on greater scale (2 h), the
NaOBr solution decomposes, lowering the reaction yield in the process.
In order to address these concerns, we first sought to alter the ketal. The introduction of
additional steric bulk was hypothesized to impart additional stability to the protecting group
and thus its tolerance to the oxidative bromination conditions. Gratifyingly, the selection of
the cyclohexyl ketal proved to have no deleterious effects on the asymmetric allylic
alkylation of enol ether 23 (Scheme 6).17 Under optimized conditions,18 chloroallylketone
24 was generated in a greatly improved 82% yield and duplicated 92% ee in comparison to
the dimethyl ketal allylic alkylation product 20.
Attempts to convert cyclohexyl ketal 24 to α-bromoketone 25 were met with consistent
results and complete conversion could be reliably accomplished under optimized
conditions,19 affording bromide 25 in nearly quantitative yield.20 As such, α-bromoketone
was immediately advanced as a crude oil to cyclopentenone 26. Application of standard
conditions for this transformation afforded enone 26, albeit in 35–40% yield.21 Modification
of these conditions, including the use of (n-Bu)3P, enabled the conversion of bromide 25 to
the desired cyclopentenone 26 in 94% yield over two steps from chloroallylketone 24.
With the establishment of a scalable, reliable route for the production of cyclopentenone 26,
we sought to advance toward the desired cis-1,3-cyclopentenediol 8. Diastereoselective 1,2-
reduction of enone 26 with diisobutylaluminum hydride (DIBAL) cleanly furnished allylic
alcohol 27 in excellent yield as a single diastereomer (Scheme 7).22 Sequential benzoylation
of alcohol 27 and fumaric acid-mediated ketal cleavage yielded protected alcohol 28, a
surrogate for the targeted cyclopentene 8. This three-step transformation from
cyclopentenone 26 not only provided cis-1,3-cyclopentenediol building block 28 in 97%
yield, but also proved to be scalable, allowing access the desired product in gram
quantities.23
In summary, we have disclosed a highly efficient and scalable route for the construction of a
cis-1,3-cyclopentenediol building block, enabling access to the cis-1,3-cyclopentanediol
framework found in a variety of natural products and natural product analogs. The
enantioselective palladium-catalyzed allylic alkylation has been used effectively to generate
the desired chiral tertiary alcohol stereocenter. Judicious choice of the ketal protecting group
allowed for successful optimization of the diastereoselective formation of the cis-1,3-diol
framework, generating diol 28 in 91% yield over 5 steps from allylic alkylation product 24.
Efforts are currently underway to employ this building block in the synthesis of members of
the norcembranoid diterpene family of natural products.
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Figure 1.
Representative natural products that possess a cis-1,3-cyclopentanediol scaffold.
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Scheme 1.
Retrosynthetic analysis of cis-1,3-cyclopentenediol 8.
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Scheme 2.
Enantioselective allylic alkylation and elaboration of cyclohexanone and dioxanone
substrates. [TBAT = Bu4NPh3SiF2, DMA = N,N-Dimethylacetamide]
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Scheme 3.
Construction of cyclopentenone 17 using an intramolecular Wittig cyclizaton.
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Scheme 4.
Construction of enone 17 by epoxidation of chloroallylketone 20.
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Scheme 5.
Construction of enone 17 by oxidative bromination of chloroallylketone 20.
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Scheme 6.
Synthetic route enabled by the crucial choice of the cyclohexyl ketal group.
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Scheme 7.
Synthetic advancement toward the desired cis-1,3-cyclopentenediol framework.
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